{"id":"W2120793461","doi":"10.1016/s0140-6736(04)17101-8","title":"Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial","year":2004,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital","funders":"Fondation Charcot; Bayer Fund; Bayer Corporation","keywords":"Medicine; Placebo; Expanded Disability Status Scale; Multiple sclerosis; Pulmonary embolism; Internal medicine; Hazard ratio; Clinical trial; Randomized controlled trial; Surgery; Confidence interval; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581568,0.0002649916,0.001495822,0.0001205572,0.000194111,0.00006016287,0.0003925624,0.0001091415,0.0001892264],"category_scores_gemma":[0.002796392,0.000156191,0.0002378223,0.0002770537,0.0002907596,0.00007866206,0.0001413487,0.0007540358,0.00009425494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002352567,"about_ca_system_score_gemma":0.0003361695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001833635,"about_ca_topic_score_gemma":0.0001220244,"domain_scores_codex":[0.9974883,0.0003234177,0.0005925354,0.0003454183,0.0005175788,0.0007328111],"domain_scores_gemma":[0.9981302,0.0007644737,0.0001743814,0.0007032705,0.0001124884,0.0001151734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9793167,0.0005714268,0.0004067311,0.0000708907,0.0003892397,0.00006165553,0.001712382,0.00008909806,0.006343207,0.00003138476,0.001149736,0.009857597],"study_design_scores_gemma":[0.96071,0.0006562474,0.03517379,0.0004158551,0.00007211951,0.00001318413,0.0003431124,0.0001251984,0.001764689,0.0001377081,0.0004247672,0.0001632952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.972129,0.003229219,0.00002509299,0.008366791,0.0002788837,0.01149109,0.00002718813,0.0001279049,0.004324792],"genre_scores_gemma":[0.9934238,0.0008998493,0.0006092528,0.0006276185,0.001476978,0.002771046,0.00001849143,0.00003301361,0.0001399999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03476706,"threshold_uncertainty_score":0.6369286,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05653824628512365,"score_gpt":0.3067764742144048,"score_spread":0.2502382279292811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}